BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 32962463)

  • 1. Ustekinumab associated chronic eosinophilic pneumonia.
    Kalra SS; Chizinga M; Trillo-Alvarez C; Papierniak ES
    J Asthma; 2021 Dec; 58(12):1670-1674. PubMed ID: 32962463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Ustekinumab-induced eosinophilic pneumonia during the course of ustekinumab therapy for plaque psoriasis].
    Amy de la Bretèque M; Appere-De Vecchi C; Zeboulon C; Zaien I; Sigal ML; Mahé E
    Ann Dermatol Venereol; 2015 Mar; 142(3):193-6. PubMed ID: 25624139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psoriasis vulgaris complicated by eosinophilic pneumonia during ustekinumab treatment.
    Yashiro M; Maejima H; Taniguchi T; Katsuoka K; Kimura M; Wada M
    Eur J Dermatol; 2013; 23(3):396-7. PubMed ID: 23728153
    [No Abstract]   [Full Text] [Related]  

  • 4. Worsening of Psoriatic Arthritis After Ustekinumab Treatment.
    Onsun N; Yalcin B; Sallahoglu K; Rezvani A
    Am J Ther; 2018; 25(3):e381-e382. PubMed ID: 29189317
    [No Abstract]   [Full Text] [Related]  

  • 5. Myasthenia gravis after etanercept and ustekinumab treatment for psoriatic arthritis: A case report.
    Nicocia G; Bonanno C; Lupica A; Toscano A; Rodolico C
    Neuromuscul Disord; 2020 Mar; 30(3):246-249. PubMed ID: 32057636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-life effectiveness of ustekinumab in inflammatory bowel disease patients with concomitant psoriasis or psoriatic arthritis: An IG-IBD study.
    Pugliese D; Daperno M; Fiorino G; Savarino E; Mosso E; Biancone L; Testa A; Sarpi L; Cappello M; Bodini G; Caprioli F; Festa S; Laino G; Maconi G; Mazzuoli S; Mocci G; Sartini A; D'Amore A; Alivernini S; Gremese E; Armuzzi A
    Dig Liver Dis; 2019 Jul; 51(7):972-977. PubMed ID: 30992173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Drug-induced interstitial lung disease (DILD) during treatment with ustekinumab].
    Sorger C; Simon JC; Treudler R
    Hautarzt; 2020 Apr; 71(4):309-312. PubMed ID: 31792580
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Borrás-Blasco J; Cortes X; Fernandez-Martinez S; Casterá E; Antequera B
    Am J Health Syst Pharm; 2017 Feb; 74(4):209-212. PubMed ID: 28179246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stroke under treatment with ustekinumab for psoriatic arthritis.
    Aboudiab M; Andréjak M; Husein T; Goëb V
    Rev Neurol (Paris); 2019 Apr; 175(4):271-272. PubMed ID: 30638925
    [No Abstract]   [Full Text] [Related]  

  • 10. How effective is ustekinumab in controlling psoriatic arthritis?
    Bonifati C; Graceffa D
    Dermatol Ther; 2016 May; 29(3):155-9. PubMed ID: 26626908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The safety of ustekinumab for the treatment of psoriatic arthritis.
    López-Ferrer A; Laiz A; Puig L
    Expert Opin Drug Saf; 2017 Jun; 16(6):733-742. PubMed ID: 28441904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flare of palmoplantar psoriasis with ustekinumab.
    Daniel BS; Baker C; Foley P
    Australas J Dermatol; 2020 Feb; 61(1):63-65. PubMed ID: 31372980
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug-induced eosinophilic pneumonia: A review of 196 case reports.
    Bartal C; Sagy I; Barski L
    Medicine (Baltimore); 2018 Jan; 97(4):e9688. PubMed ID: 29369189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of bullous pemphigoid during treatment of psoriatic onycho-pachydermo periostitis with ustekinumab.
    Nakayama C; Fujita Y; Watanabe M; Shimizu H
    J Dermatol; 2015 Oct; 42(10):996-8. PubMed ID: 26010891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic cough and an atypical pattern of peripheral pulmonary opacities: A case report secondary to suspected drug onset.
    Alas R; Williams MT; Yamin G; Rofoogaran M
    J Asthma; 2018 Jan; 55(1):106-110. PubMed ID: 28402696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paradoxical psoriatic arthritis in a patient with psoriasis treated with ustekinumab.
    Čarija A; Ivić I; Marasović-Krstulović D; Puizina-Ivić N
    Rheumatology (Oxford); 2015 Nov; 54(11):2114-6. PubMed ID: 26242857
    [No Abstract]   [Full Text] [Related]  

  • 17. Pyoderma gangrenosum arising during treatment of psoriasis with adalimumab: Effectiveness of ustekinumab.
    Benzaquen M; Monnier J; Beaussault Y; Rouby F; Berbis P
    Australas J Dermatol; 2017 Nov; 58(4):e270-e271. PubMed ID: 28660635
    [No Abstract]   [Full Text] [Related]  

  • 18. [Efficacy and safety of ustekinumab in psoriatic arthritis after anti-TNFα failure in routine practice].
    Michel M; Reguiai Z; Fauconier M; Brochot P; Eschard JP; Salmon JH
    Therapie; 2016 Jun; 71(3):281-6. PubMed ID: 27235651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is ustekinumab effective for psoriatic arthritis with insufficient response to initial treatment?
    Venegas-Iribarren S; Andino-Navarrete R
    Medwave; 2018 Mar; 18(2):e7174. PubMed ID: 29522505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A case of eosinophilic pneumonia due to Nicolase (serrapeptase) after recovery from acute eosinophilic pneumonia].
    Kai N; Shirai R; Hirata N; Iwata A; Umeki K; Ishii H; Kishi K; Tokimatsu I; Hiramatsu K; Kadota J
    Nihon Kokyuki Gakkai Zasshi; 2009 Mar; 47(3):254-8. PubMed ID: 19348276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.